Report Detail
Global Neurogenic Detrusor Overactivity(NDO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4565008 |
- 07 November, 2023 |
- Global |
- 79 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Neurogenic Detrusor Overactivity(NDO) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
NDO is a subtype of neurogenic lower urinary tract symptoms that are often caused by neurological disorders, including spinal cord injury, multiple sclerosis, and Parkinson's disease. Clinical manifestations include increased daytime urinary frequency, urinary urgency, and acute urinary incontinence, which seriously affects the patient's quality of life.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Neurogenic Detrusor Overactivity(NDO) industry chain, the market status of Aldult (Non-surgical Treatment, Surgical Treatment), Child (Non-surgical Treatment, Surgical Treatment), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurogenic Detrusor Overactivity(NDO).
Regionally, the report analyzes the Neurogenic Detrusor Overactivity(NDO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurogenic Detrusor Overactivity(NDO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurogenic Detrusor Overactivity(NDO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurogenic Detrusor Overactivity(NDO) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Non-surgical Treatment, Surgical Treatment).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurogenic Detrusor Overactivity(NDO) market.
Regional Analysis: The report involves examining the Neurogenic Detrusor Overactivity(NDO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurogenic Detrusor Overactivity(NDO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurogenic Detrusor Overactivity(NDO):
Company Analysis: Report covers individual Neurogenic Detrusor Overactivity(NDO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurogenic Detrusor Overactivity(NDO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Aldult, Child).
Technology Analysis: Report covers specific technologies relevant to Neurogenic Detrusor Overactivity(NDO). It assesses the current state, advancements, and potential future developments in Neurogenic Detrusor Overactivity(NDO) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurogenic Detrusor Overactivity(NDO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurogenic Detrusor Overactivity(NDO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Non-surgical Treatment
Surgical Treatment
Follow-up Treatment
Market segment by Application
Aldult
Child
Major players covered
Astellas Pharma
AbbVie
Medtronic
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurogenic Detrusor Overactivity(NDO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurogenic Detrusor Overactivity(NDO), with price, sales, revenue and global market share of Neurogenic Detrusor Overactivity(NDO) from 2018 to 2023.
Chapter 3, the Neurogenic Detrusor Overactivity(NDO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurogenic Detrusor Overactivity(NDO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurogenic Detrusor Overactivity(NDO) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurogenic Detrusor Overactivity(NDO).
Chapter 14 and 15, to describe Neurogenic Detrusor Overactivity(NDO) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Neurogenic Detrusor Overactivity(NDO)
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Neurogenic Detrusor Overactivity(NDO) Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Non-surgical Treatment
- 1.3.3 Surgical Treatment
- 1.3.4 Follow-up Treatment
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Neurogenic Detrusor Overactivity(NDO) Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Aldult
- 1.4.3 Child
- 1.5 Global Neurogenic Detrusor Overactivity(NDO) Market Size & Forecast
- 1.5.1 Global Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Neurogenic Detrusor Overactivity(NDO) Sales Quantity (2018-2029)
- 1.5.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Astellas Pharma
- 2.1.1 Astellas Pharma Details
- 2.1.2 Astellas Pharma Major Business
- 2.1.3 Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Product and Services
- 2.1.4 Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Astellas Pharma Recent Developments/Updates
- 2.2 AbbVie
- 2.2.1 AbbVie Details
- 2.2.2 AbbVie Major Business
- 2.2.3 AbbVie Neurogenic Detrusor Overactivity(NDO) Product and Services
- 2.2.4 AbbVie Neurogenic Detrusor Overactivity(NDO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 AbbVie Recent Developments/Updates
- 2.3 Medtronic
- 2.3.1 Medtronic Details
- 2.3.2 Medtronic Major Business
- 2.3.3 Medtronic Neurogenic Detrusor Overactivity(NDO) Product and Services
- 2.3.4 Medtronic Neurogenic Detrusor Overactivity(NDO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Medtronic Recent Developments/Updates
3 Competitive Environment: Neurogenic Detrusor Overactivity(NDO) by Manufacturer
- 3.1 Global Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Manufacturer (2018-2023)
- 3.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Neurogenic Detrusor Overactivity(NDO) by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Neurogenic Detrusor Overactivity(NDO) Manufacturer Market Share in 2022
- 3.4.2 Top 6 Neurogenic Detrusor Overactivity(NDO) Manufacturer Market Share in 2022
- 3.5 Neurogenic Detrusor Overactivity(NDO) Market: Overall Company Footprint Analysis
- 3.5.1 Neurogenic Detrusor Overactivity(NDO) Market: Region Footprint
- 3.5.2 Neurogenic Detrusor Overactivity(NDO) Market: Company Product Type Footprint
- 3.5.3 Neurogenic Detrusor Overactivity(NDO) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Neurogenic Detrusor Overactivity(NDO) Market Size by Region
- 4.1.1 Global Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Region (2018-2029)
- 4.1.2 Global Neurogenic Detrusor Overactivity(NDO) Consumption Value by Region (2018-2029)
- 4.1.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price by Region (2018-2029)
- 4.2 North America Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018-2029)
- 4.3 Europe Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018-2029)
- 4.4 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018-2029)
- 4.5 South America Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018-2029)
- 4.6 Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 5.2 Global Neurogenic Detrusor Overactivity(NDO) Consumption Value by Type (2018-2029)
- 5.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 6.2 Global Neurogenic Detrusor Overactivity(NDO) Consumption Value by Application (2018-2029)
- 6.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price by Application (2018-2029)
7 North America
- 7.1 North America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 7.2 North America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 7.3 North America Neurogenic Detrusor Overactivity(NDO) Market Size by Country
- 7.3.1 North America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Country (2018-2029)
- 7.3.2 North America Neurogenic Detrusor Overactivity(NDO) Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 8.2 Europe Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 8.3 Europe Neurogenic Detrusor Overactivity(NDO) Market Size by Country
- 8.3.1 Europe Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Neurogenic Detrusor Overactivity(NDO) Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Market Size by Region
- 9.3.1 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Neurogenic Detrusor Overactivity(NDO) Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 10.2 South America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 10.3 South America Neurogenic Detrusor Overactivity(NDO) Market Size by Country
- 10.3.1 South America Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Country (2018-2029)
- 10.3.2 South America Neurogenic Detrusor Overactivity(NDO) Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Neurogenic Detrusor Overactivity(NDO) Market Size by Country
- 11.3.1 Middle East & Africa Neurogenic Detrusor Overactivity(NDO) Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Neurogenic Detrusor Overactivity(NDO) Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Neurogenic Detrusor Overactivity(NDO) Market Drivers
- 12.2 Neurogenic Detrusor Overactivity(NDO) Market Restraints
- 12.3 Neurogenic Detrusor Overactivity(NDO) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Neurogenic Detrusor Overactivity(NDO) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Neurogenic Detrusor Overactivity(NDO)
- 13.3 Neurogenic Detrusor Overactivity(NDO) Production Process
- 13.4 Neurogenic Detrusor Overactivity(NDO) Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Neurogenic Detrusor Overactivity(NDO) Typical Distributors
- 14.3 Neurogenic Detrusor Overactivity(NDO) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Neurogenic Detrusor Overactivity(NDO). Industry analysis & Market Report on Neurogenic Detrusor Overactivity(NDO) is a syndicated market report, published as Global Neurogenic Detrusor Overactivity(NDO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Neurogenic Detrusor Overactivity(NDO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
